「no」の検索結果
166件：16～20件目を表示
-
Business Activities | About Senju | SENJU Pharmaceutical
nate instincts and behaviors are based on our five senses. Seeing (eyes), hearing (ears), smelling (nose), taste (mouth), and touching (skin). These normal functions can be said to be the origin of a ...
http://www.senju.co.jp/english/about/business/ -
千寿製薬株式会社
5 Obtained manufacturing and marketing approval in Japan for Avarept® Ophthalmic suspension 0.3%, a novel treatment of Dry Eye Disease through Transient Receptor Potential cation channel subfamily V m...
http://www.senju.co.jp/english/ -
Production | About Senju | SENJU Pharmaceutical
tical, are being produced in the plant in an advanced production environment using cutting-edge technology and are being delivered throughout Japan and worldwide. Production base Manufacturing Plant F...
http://www.senju.co.jp/english/about/production.html -
学会发表 | 研究与开发 | 千寿制药株式会社
le-Masked, Placebo-Controlled Phase 3 Pivotal Study – Yuichi Hori, MD, PhD; Tomoyuki Wada, PhD; Kazunori Omatsu, BSc the 59th Congress of the European Societies of Toxicology 開催日：2025年9月14日～2025年9月17日...
http://www.senju.co.jp/chinese/rd/society/ -
千寿製薬株式会社
日 Obtained manufacturing and marketing approval in Japan for Avarept® Ophthalmic suspension 0.3%, a novel treatment of Dry Eye Disease through Transient Receptor Potential cation channel subfamily V m...
http://www.senju.co.jp/chinese/